文献速递妇科生殖医学

腹腔镜卵巢打孔术式变异对克罗米芬抵抗多囊卵巢综合征不孕患者的Meta分析

Variation of Laparoscopic Ovarian Drilling for Clomiphene Citrate-resistant Patients with Polycystic Ovary Syndrome and Infertility: A Meta-analysis.
PubMed 文献 · J Minim Invasive Gynecol · 2020-04-11

该Meta分析纳入20项RCT共1615例克罗米芬抵抗的多囊卵巢综合征不孕患者,比较新型腹腔镜卵巢打孔术式与标准双侧打孔。单侧打孔在妊娠、排卵、流产和月经恢复方面与双侧无显著差异,但新型术式证据不足,结论尚需更多长期研究。

要点

  • 单侧腹腔镜卵巢打孔在生殖结局上与双侧打孔无显著差异,或可替代双侧打孔。
  • 经阴道水腹腔镜和微型打孔等新型术式的疗效与安全性证据不足。
  • 打孔数量、打孔时长及术后抗苗勒管激素或窦卵泡数的最佳证据不明确。

核心结论

  • 单侧腹腔镜卵巢打孔似可替代传统双侧打孔用于克罗米芬抵抗的多囊卵巢综合征患者。
  • 仍需更多涉及长期生殖疗效、不良事件及不同打孔术式的研究。

研究设计与样本

  • 系统检索多个电子数据库至2019年2月,纳入评估腹腔镜卵巢打孔的随机对照试验。
  • 共纳入20项RCT、1615例克罗米芬抵抗的多囊卵巢综合征不孕患者。
  • 由2名作者分别评估研究质量与偏倚风险,证据质量基于GRADE五个结局领域评定为中等至极低。

主要发现

  • 仅4项研究报告活产。
  • 经阴道水腹腔镜(1项RCT)和微型打孔(3项RCT)的疗效与安全性证据不足。
  • 打孔数量、打孔时长及术后抗苗勒管激素或窦卵泡数的证据无定论。

临床怎么用

  • 对克罗米芬抵抗的多囊卵巢综合征不孕患者,可考虑单侧腹腔镜卵巢打孔替代双侧打孔。
  • 新型打孔术式(经阴道水腹腔镜、微型打孔)暂不宜作为常规推荐,需个体化评估。
  • 打孔数量、时长及术后卵巢储备监测尚无明确标准,应结合临床判断。

局限性

  • 纳入研究的证据质量多为中等至极低。
  • 仅4项研究报告活产,长期生殖疗效数据有限。
  • 新型术式相关RCT数量少(经阴道水腹腔镜1项、微型打孔3项),证据不足。
  • 打孔数量、时长及术后抗苗勒管激素或窦卵泡数等关键参数无定论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate novel surgical variations of laparoscopic ovarian drilling (LOD) and compare with standard bilateral LOD. DATA SOURCES: Electronic databases were searched, including Cochrane database, CENTRAL, Ovid MEDLINE, Embase, PsycINFO, PubMed, Virtual Health Library, OpenSIGLE, ClinicalTrials.gov, ISRCTN, and The Chinese Clinical Trial Register in February 2019. METHODS OF STUDY SELECTION: Randomized controlled trials (RCTs) evaluating LOD for patients with clomiphene citrate-resistant polycystic ovary syndrome and infertility and reporting reproductive outcomes, surgical complications, serum indexes, menses resumption, and ultrasound results were included. Quality and risk of bias were evaluated by 2 authors, respectively. TABULATION, INTEGRATION, AND RESULTS: A total of 20 RCTs with 1615 patients were included. Evaluation of the quality of evidence for each study was based on each study's limitations of 5 outcome domains described by the Grading of Recommendations, Assessment, Development, and Evaluation and found to be moderate to very low. Live births were only reported by 4 studies. Unilateral LOD did not differ with bilateral LOD in reproductive outcomes, such as pregnancy (p = .11, I2 = 75%), ovulation (p = .08, I2 = 0%), miscarriage (p = .61), and menstruation resumption (p = .06). There was insufficient evidence regarding efficacy and safety of novel methods of LOD, such as transvaginal hydrolaparoscopy (1 RCT) and micro-LOD (3 RCTs). Evidence regarding the suitable number of ovarian punctures, duration of drilling, and antimüllerian hormone or antral follicle numbers following LOD were inconclusive. CONCLUSION: Unilateral LOD seems to be suitable replacement for conventional bilateral LOD for clomiphene citrate-resistant polycystic ovary syndrome, although more studies involving long-term reproductive efficacy, adverse events, and varying forms of LOD are warranted.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Zhou K, Luo X, et al. Variation of Laparoscopic Ovarian Drilling for Clomiphene Citrate-resistant Patients with Polycystic Ovary Syndrome and Infertility: A Meta-analysis. J Minim Invasive Gynecol. 2020. PMID: 32289557. doi:10.1016/j.jmig.2019.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。